WHO ICTRP trial

Clinical research study to assess the safety and effectiveness of…

EUCTR2007-007129-38-IE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2007-007129-38-IE
Public title Clinical research study to assess the safety and effectiveness of alpha1-proteinase inhibitor (A1-PI) administered by intravenous application to patients with alpha1-proteinase deficiency and emphysema who have completed the 2-year treatment and observation period in the Phase III/IV Zemaira® CE1226_4001.
Scientific title An open-label, non-controlled, multicenter, multinational Study to evaluate the Efficacy and Safety of Zemaira® administration in Chronic Augmentation and Maintenance Therapy in Subjects with Emphysema due to Alpha1-Proteinase Inhibitor Deficiency who completed Clinical Study CE1226_4001
Primary sponsor CSL Behring GmbH
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Estonia;Czech Republic;Canada;Finland;Poland;Ireland;Romania;Denmark;Australia;Germany;Sweden
Conditions Chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor (A1-PI) deficiency and clinical evidence of emphysema. MedDRA version: 17.0 Level: LLT Classification code 10001811 Term: Alpha-1 proteinase…
Interventions Product Name: Alpha1-Proteinase Inhibitor / Zemaira® Product Code: CE1226 Pharmaceutical Form: Powder and solvent for solution for injection INN or Proposed INN: There is no recommended INN Current Sponsor code: CE1226 Other descriptive…
Registration date Nov 1, 2008
Target size 140
Secondary IDs CE1226_3001
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations